Pharmaceutical Division
Suzetrigine
Suzetrigine is a selective sodium channel blocker for pain management.
Under developmentTreatment of painCAS 2070015-02-8
Quality Assured
Sodium channel blocker
Under development
Detailed technical, regulatory, and supply information is available for commercial evaluation.
Technical Overview
Suzetrigine – CAS 2070015-02-8
CAS Number
2070015-02-8
Category
Treatment of pain
Therapeutic Class
Sodium channel blocker
Description
Suzetrigine is a selective sodium channel blocker for pain management.
Applications
- Pain management
- Neuropathic pain
Handling & Supply Details
Packaging
Standard export packaging in double-lined HDPE drums or fiber drums with inner poly liners; custom pack sizes available on request.
Product Inquiry
Disclaimer
Products offered are intended strictly for R&D, registration and/or export purposes only. The responsibility for ensuring that the product does not infringe any third-party patent or intellectual property rights in the destination country rests solely with the buyer.